Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
CC-99712 for Multiple Myeloma
Recruiting1 awardPhase 1
Toronto, Ontario
This trial is testing a new drug, CC-99712, alone or with another drug, BMS-986405, in patients with a type of blood cancer that has come back and doesn't respond to usual treatments. Researchers will gradually find the safest and most effective amount while checking for side effects and cancer treatment effectiveness.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service